PHARIXIA

This brand name is authorized in Canada, Hong Kong SAR China.

Active ingredients

The drug PHARIXIA contains one active pharmaceutical ingredient (API):

1	Benzydamine UNII K2GI407R4Q - BENZYDAMINE HYDROCHLORIDE
	Benzydamine exerts an anti-inflammatory and analgesic action by stabilising the cellular membrane and inhibiting prostaglandin synthesis.
	Read more about Benzydamine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
PHARIXIA Mouthwash	MPI, CA: SPM	Health Products and Food Branch (CA)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A01AD02	Benzydamine	A Alimentary tract and metabolism → A01 Stomatological preparations → A01A Stomatological preparations → A01AD Other agents for local oral treatment
Discover more medicines within A01AD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02229777, 02494434
HK	Department of Health Drug Office	64739